Immunosuppression induced by "toxohormone" from mouse tumor cells in culture

Area of Science:

• Immunology
• Cancer Biology
• Biochemistry

Background:

• Tumor-derived factors can modulate the host immune system.
• Understanding these factors is crucial for cancer immunotherapy.
• Methylcholanthrene-induced fibrosarcomas are a model for studying tumor-host interactions.

Purpose of the Study:

• To investigate the immunosuppressive properties of tumor culture toxohormone (TCT).
• To characterize the biochemical nature of TCT's immunosuppressive activity.

Main Methods:

• Cultured MBQA mouse tumor cells to obtain TCT.
• Assessed TCT's effect on mouse spleen cell mitogenic responsiveness (PHA, LPS) in vitro.
• Evaluated TCT's impact on antibody formation to sheep red blood cells (SRBC) in vitro.
• Tested the stability of TCT's activity after heat, trypsin, DNase, and RNase treatments.

Main Results:

• TCT suppressed the mitogenic response of mouse spleen cells to PHA and LPS.
• TCT inhibited in vitro antibody formation to SRBC.
• The immunosuppressive activity of TCT was inactivated by heating at 100°C.
• Trypsin treatment abolished TCT's immunosuppressive activity.
• DNase and RNase treatments did not affect TCT's immunosuppressive activity.

Conclusions:

• Tumor culture toxohormone (TCT) exhibits significant immunosuppressive effects on cellular and humoral immunity in vitro.
• The immunosuppressive factor in TCT is proteinaceous in nature, as indicated by its sensitivity to heat and trypsin, and resistance to nucleases.
• These findings highlight TCT as a potential mediator of tumor-induced immunosuppression and a target for therapeutic intervention.